Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

85 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Predictive factors for central nervous system involvement in non-Hodgkin's lymphoma: significance of very high serum LDH concentrations.
Tomita N, Kodama F, Sakai R, Koharasawa H, Hattori M, Taguchi J, Fujita H, Tanabe J, Fujisawa S, Fukawa H, Harano H, Kanamori H, Miyashita H, Matsuzaki M, Ogawa K, Motomura S, Maruta A, Ishigatsubo Y. Tomita N, et al. Among authors: harano h. Leuk Lymphoma. 2000 Jul;38(3-4):335-43. doi: 10.3109/10428190009087024. Leuk Lymphoma. 2000. PMID: 10830740
[Clinical usefulness of ondansetron hydrochloride for nausea and vomiting during repeated courses of chemotherapy for malignant lymphoma--impact of prognosis announcement on anti-emetic effect and evaluation of patient perception of chemotherapy-associated adverse events].
Kodama F, Mohri H, Motomura S, Fukawa H, Tanabe J, Koharasawa H, Kanamori H, Hashimoto Y, Harano H, Sakai R, Tomita N, Fujimaki K, Takemura S, Hattori M. Kodama F, et al. Among authors: harano h. Gan To Kagaku Ryoho. 2002 Feb;29(2):273-9. Gan To Kagaku Ryoho. 2002. PMID: 11865634 Clinical Trial. Japanese.
[Trial of front-line intensive chemotherapy followed by peripheral blood stem cell transplantation in high-intermediate and high risk non-Hodgkin's lymphoma patients].
Motomura S, Hashimoto C, Kodama F, Maruta A, Sakai R, Fujita H, Tomita N, Fujisawa S, Harano H, Koharazawa H, Fujimaki K, Kanamori H, Ishigatsubo Y. Motomura S, et al. Among authors: harano h. Rinsho Ketsueki. 2005 May;46(5):350-7. Rinsho Ketsueki. 2005. PMID: 16444968 Clinical Trial. Japanese.
Long-term outcome of L86 and L97 protocols for adult acute lymphoblastic leukemia.
Koharazawa H, Kanamori H, Sakai R, Hashimoto C, Takemura S, Hattori M, Taguchi J, Fujimaki K, Tomita N, Fujita H, Fujisawa S, Harano H, Ogawa K, Motomura S, Maruta A, Ishigatsubo Y. Koharazawa H, et al. Among authors: harano h. Leuk Lymphoma. 2008 Nov;49(11):2133-40. doi: 10.1080/10428190802464711. Leuk Lymphoma. 2008. PMID: 19021056 Clinical Trial.
Analysis of outcomes in patients with supra-diaphragmatic vs infra-diaphragmatic diffuse large B cell lymphoma treated with R-CHOP therapy.
Nakajima Y, Tomita N, Itabashi M, Miyashita K, Watanabe R, Miyazaki T, Tachibana T, Takasaki H, Kawasaki R, Tanaka M, Hashimoto C, Yamazaki E, Taguchi J, Fujimaki K, Sakai R, Fujita H, Fujisawa S, Harano H, Motomura S, Ishigatsubo Y. Nakajima Y, et al. Among authors: harano h. Leuk Res. 2015 Feb;39(2):198-203. doi: 10.1016/j.leukres.2014.11.030. Epub 2014 Dec 8. Leuk Res. 2015. PMID: 25541027 Clinical Trial.
Residual leukemic cell counts in the bone marrow at the end point of intensive induction therapy may be a prognostic factor for acute myeloblastic leukemia in adults.
Fujisawa S, Maruta A, Motomura S, Fukawa H, Kanamori H, Ogawa K, Matsuzaki M, Miyashita H, Harano H, Murata T, Sakai R, Mohri H, Kodama F, Okubo T. Fujisawa S, et al. Among authors: harano h. Leuk Lymphoma. 1998 Mar;29(1-2):161-70. doi: 10.3109/10428199809058391. Leuk Lymphoma. 1998. PMID: 9638985 Clinical Trial.
85 results